COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,732 Articles (22,502 medRxiv, 8,230 bioRxiv)

Most recent first Previous |  Page 1189: Articles 11881-11890  | Next

mRNA COVID-19 Vaccination and Development of CMR-confirmed Myopericarditis
Kafil, T., Lamacie, M. M., Chenier, S., Taggart, H., Ghosh, N., Dick, A., Small, G., Liu, P., Beanlands, R. S., Mielniczuk, L., Birnie, D., Crean, A. M.
10.1101/2021.09.13.21262182 — Posted: 2021-09-16 Discussion: Onsite | Offsite
Factors Influencing The First and Second Peak of COVID-19 Global Cases: A Survival Analysis
Oshan, Y. A., Zainab, B., Bandyopadhyay, D., Rahaman Khan, H.
10.1101/2021.09.13.21263497 — Posted: 2021-09-16 Discussion: Onsite
Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staffs with a history of allergy.
Inoue, S., Igarashi, A., Morikane, K., Hachiya, O., Watanabe, M., Kakehata, S., Sato, S., Ueno, Y.
10.1101/2021.09.13.21263473 — Posted: 2021-09-16 Discussion: Offsite
Aging-related cell type-specific pathophysiologic immune responses that exacerbate disease severity in aged COVID-19 patients
Hou, Y., Zhou, Y., Gack, M. U., Luo, Y., Jehi, L., Chan, T., Yu, H., Eng, C., Pieper, A. A., Cheng, F.
10.1101/2021.09.13.21263504 — Posted: 2021-09-16
Platelet polyphosphate and SARS-Cov-2 mRNA-vaccine-induced inflammatory side-effects: a pilot study
Uematsu, T., Sato, A., Aizawa, H., Tsujino, T., Watanabe, T., Isobe, K., Kawabata, H., Kitamura, Y., Tanaka, T., Kawase, T.
10.1101/2021.09.13.21263437 — Posted: 2021-09-16
Social Capital Dimensions are Differentially Associated with COVID-19 Vaccinations, Masks, and Physical Distancing
Ferwana, I., Varshney, L. R.
10.1101/2021.09.13.21263543 — Posted: 2021-09-16
High Seroconversion Rates Amongst Black and Hispanics With Hematologic Malignancies after SARS-CoV-2 Vaccination
Shapiro, L. C., Thakkar, A., Gali, R., Gonzalez-Lugo, J. D., Bazarbachi, A.-H., Rahman, S., Pradhan, K., Fehn, K., Abreu, M., Kornblum, N., Gritsman, K., Goldfinger, M., Shastri, A., Mantzaris, I., Braunschweig, I., Halmos, B., Verma, A., McCort, M., Bachier-Rodriguez, L., Sica, R. A.
10.1101/2021.09.13.21263365 — Posted: 2021-09-16
Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not facilitate antibody-dependent enhance of viral infection.
Clark, N. M., Janaka, S. K., Hartman, W., Stramer, S., Goodhue, E., Weiss, J., Evans, D. T., Connor, J. P.
10.1101/2021.09.14.460394 — Posted: 2021-09-16
A genetic trap in yeast for inhibitors of SARS-CoV-2 main protease
Alalam, H., Sigurdardottir, S., Bourgard, C., Tiukova, I. A., King, R. D., Grötli, M., Sunnerhagen, P.
10.1101/2021.09.14.460411 — Posted: 2021-09-16
Robust clinical detection of SARS-CoV-2 variants by RT-PCR/MALDI-TOF multi-target approach
Hernandez, M. M., Banu, R., Gonzalez-Reiche, A. S., van de Guchte, A., Khan, Z., Shrestha, P., Cao, L., Chen, F., Shi, H., Hanna, A., Alshammary, H., Fabre, S., Amoako, A., Obla, A., Alburquerque, B., Helena Patino, L., Ramirez, J. D., Sebra, R., Gitman, M. R., Nowak, M. D., Cordon-Cardo, C., Schutzbank, T. E., Simon, V., van Bakel, H., Sordillo, E. M., Paniz Mondolfi, A. E.
10.1101/2021.09.09.21263348 — Posted: 2021-09-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).